Turing Pharmaceuticals CEO Martin Shkreli has become one of the most reviled people in America after his company raised the price of a drug used to treat life-threatening parasitic infections in AIDS patients from $13.50 per pill to $750.
Among the invectives on Twitter: “The most punchable face on the planet … howling wasteland of his soul … utter callousness towards human suffering … garbage monster … united every possible group in their hatred of him … parasite … should be shunned for eternity.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]